Your browser doesn't support javascript.
loading
A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
Tong, Zhen; Guo, Jingxu; Glen, Robert C; Morrell, Nicholas W; Li, Wei.
Affiliation
  • Tong Z; The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0QQ, United Kingdom.
  • Guo J; The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0QQ, United Kingdom.
  • Glen RC; Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, United Kingdom.
  • Morrell NW; Department of Metabolism, Digestion and Reproduction, Division of Systems Medicine, Imperial College, London, SW7 2AZ, United Kingdom.
  • Li W; The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0QQ, United Kingdom.
Sci Rep ; 9(1): 13446, 2019 09 17.
Article in En | MEDLINE | ID: mdl-31530856
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Bone Morphogenetic Proteins / Activin Receptors, Type II Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Bone Morphogenetic Proteins / Activin Receptors, Type II Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom